The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy

The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy

This study evaluated the clinical characteristics of head and neck cancer (HNC) patients with hepatitis B (HBV) or hepatitis C (HCV) who underwent concurrent chemoradiotherapy (CCRT) and examined the prognostic impact of antiviral therapies. In a 19-year retrospective analysis of 8224 HNC patients t...

Full description

Bibliographic Details
Main Authors:	Yu-Ming Wang, Sheng-Dean Luo, Ching-Nung Wu, Shao-Chun Wu, Wei-Chih Chen, Yao-Hsu Yang, Tai-Jan Chiu
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Biomedicines
Subjects:	head and neck cancer viral hepatitis chemoradiation antiviral therapy prognosis
Online Access:	https://www.mdpi.com/2227-9059/11/11/2946

Similar Items

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Kulsoom Begum, et al.
Published: (2016-08-01)

Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer
by: Lekha Madhavan Nair, et al.
Published: (2017-01-01)

Comparison of Sequential Boost and Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in Treatment of Head and Neck Carcinoma: A Prospective Interventional Study
by: Abhishek Arora, et al.
Published: (2022-03-01)

A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer
by: Ai Horinouchi, et al.
Published: (2023-09-01)

Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once‐a‐week versus once‐every‐3‐weeks cisplatin
by: Nandini S. Menon, et al.
Published: (2022-11-01)

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study
by: Pergolizzi Stefano, et al.
Published: (2011-11-01)

Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center
by: Fred Muller dos Santos, et al.
Published: (2021-01-01)

Concurrent Weekly Cisplatin and Simultaneous Integrated Boost-IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma—An Institutional Experience
by: Imtiaz Ahmed, et al.
Published: (2022-07-01)

Aspiration pneumonia in head and neck cancer patients undergoing concurrent chemoradiation from India: Findings from a post hoc analysis of a phase 3 study
by: Vijay Patil, et al.
Published: (2021-10-01)

Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis
by: Vanita Noronha, et al.
Published: (2021-05-01)

First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m<sup>2</sup> Cisplatin for Locally Advanced Head and Neck Cancer
by: Inga Zwaan, et al.
Published: (2023-06-01)

Review of Outcomes after Salvage Surgery for Recurrent Squamous Cell Carcinoma of the Head and Neck
by: Dana M. Hartl, et al.
Published: (2023-09-01)

Treatment of Sinonasal Undifferentiated Carcinoma with TPF and Concurrent Chemo-Radiation: Case Report and Literature Review
by: Emily Barber, et al.
Published: (2019-02-01)

Comparison of Safety and Efficacy of Two Different Chemotherapy Dosing Schedules Used in Concurrent Chemoradiation of Head and Neck Cancer: A Retrospective Experience from a Tertiary Cancer Care Institute of Eastern India
by: Sayoni Bhanja, et al.
Published: (2023-07-01)

Role of Repeat PET/CT Imaging in Head and Neck Cancer Following Initial Incomplete PET/CT Response to Chemoradiation
by: Austin J. Iovoli, et al.
Published: (2021-03-01)

Prognostic Factors Predict Oncological Outcome in Older Patients With Head and Neck Cancer Undergoing Chemoradiation Treatment
by: Carmen Stromberger, et al.
Published: (2021-02-01)

The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey
by: Sapna Krishnamurthy, et al.
Published: (2022-05-01)

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
by: Chien Chih-Yen, et al.
Published: (2011-03-01)

Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy
by: Hayashi N, et al.
Published: (2021-11-01)

Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection
by: Dheeraj Pandey, et al.
Published: (2022-12-01)

A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer
by: Dirk Rades, et al.
Published: (2023-07-01)

Lymph Node Yield and Ratio in Selective and Modified Radical Neck Dissection in Head and Neck Cancer—Impact on Oncological Outcome
by: Sean C. Sheppard, et al.
Published: (2021-05-01)

Association of cytochrome P450 2C9 polymorphism with locally advanced head and neck squamous cell carcinoma and response to concurrent cisplatin-based radical chemoradiation
by: Sayan Paul, et al.
Published: (2014-01-01)

Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation
by: Targain Elisha Servorip, et al.
Published: (2023-10-01)

Once-a-week versus once-every-3-weeks cisplatin in patients receiving chemoradiation for locally advanced head-and-neck cancer: A survey of practice in India
by: Gautam Goyal, et al.
Published: (2018-01-01)

The Effect of Radiation and Chemoradiation Therapy on the Head and Neck Mucosal Microbiome: A Review
by: Ivry Zagury-Orly, et al.
Published: (2021-12-01)

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
by: Hundo Cho, et al.
Published: (2022-05-01)

CELECOXIB - Chemoradiation therapy for reducing mucositis and other acute side effects in advance head and neck carcinoma
by: Izadi Sh, et al.
Published: (2009-02-01)

Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT
by: Vinidh Paleri, et al.
Published: (2018-04-01)

Disease‐induced and treatment‐induced alterations in body composition in locally advanced head and neck squamous cell carcinoma
by: Anna C.H. Willemsen, et al.
Published: (2020-02-01)

Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study
by: Christopher N Rumley, et al.
Published: (2017-07-01)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
by: Qiuji Wu, et al.
Published: (2021-10-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)

Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer
by: Rhiannon Mellor, et al.
Published: (2024-02-01)

A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
by: Pei-Wei Huang, et al.
Published: (2018-04-01)

Diffusion-weighted magnetic resonance imaging (DWMRI) of head and neck squamous cell carcinoma: could it be an imaging biomarker for prediction of response to chemoradiation therapy
by: Hanan Mohamed Khattab, et al.
Published: (2020-10-01)

Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
by: Hiromichi Shirasu, et al.
Published: (2020-03-01)

The Impact of Radiation to Epicardial Adipose Tissue on Prognosis of Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy and Esophagectomy
by: Hung-Chi Tai, et al.
Published: (2021-04-01)